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Determination of Chemical Irritation Potential
Using a Defined Gene Signature Set on
Tissue-Engineered Human Skin Equivalents
Amy L. Harding1, Craig Murdoch1, Simon Danby2, Md Zobaer Hasan3, Hirofumi Nakanishi3,
Tetsuo Furuno3, Sirwan Hadad4, Robert Turner5 and Helen E. Colley1
There are no physical or visual manifestations that define skin sensitivity or irritation; a subjective diagnosis is
made on the basis of the evaluation of clinical presentations, including burning, prickling, erythema, and
itching. Adverse skin reaction in response to topically applied products is common and can limit the use of
dermatological or cosmetic products. The purpose of this study was to evaluate the use of human skin
equivalents based on immortalized skin keratinocytes and evaluate the potential of a 22-gene panel in com-
bination with multivariate analysis to discriminate between chemicals known to act as irritants and those that
do not. Test compounds were applied topically to full-thickness human skin equivalent or human ex vivo skin
and gene signatures determined for known irritants and nonirritants. Principle component analysis showed the
discriminatory potential of the 22-gene panel. Linear discrimination analysis, performed to further refine the
gene set for a more high-throughput analysis, identified a putative seven-gene panel (IL-6, PTGS2, ATF3, TRPV3,
MAP3K8, HMGB2, and matrix metalloproteinase gene MMP-3) that could distinguish potential irritants from
nonirritants. These data offer promise as an in vitro prediction tool, although analysis of a large chemical test
set is required to further evaluate the system.
JID Innovations (2021);1:100011 doi:10.1016/j.xjidi.2021.100011
INTRODUCTION
Skin sensitivity or irritation can be induced by exposure to
exogenous stimuli that can be physical, in the form of UV
light and wind; environmental, such as atmospheric pollut-
ants; thermal, manifesting as heat or cold; or chemical en-
tities, for example, constituents of cosmetics, Hþ ions, and
drugs (Talagas and Misery, 2019). The topical application of
dermatological agents that cause adverse skin sensitivity or
irritation is a common reason for poor treatment compliance
and can restrict therapeutic options. Moreover, adverse skin
reaction owing to cosmetics and skincare products is a sig-
nificant problem affecting a large proportion of individuals,
with 78% of people with sensitive skin reporting avoidance
of dermatological products because of potential adverse ef-
fects (Farage et al., 2006). Currently, there are no physical or
visual manifestations that define skin sensitivity, with 50% of
adults reporting dermal sensitivity without any other clinical
signs of inflammation (Ständer et al., 2009). Therefore, a
subjective diagnosis is based on various sensory clinical
manifestations, including burning, tingling, stinging, prick-
ling, and itching (Misery et al., 2017). This range of symp-
toms is collectively termed sensitive skin syndrome and can
affect people with seemingly healthy skin. Skin irritation is
more closely related to inflammation that may be initiated in
a specific or nonspecific manner. The molecular mechanism
for both skin sensitivity and irritation is still poorly defined
and is likely to consist of interplay between keratinocytes
(KCs) and dermal fibroblasts, which constitute the main mass
of cells in the skin, along with other cell types from the
neuronal and immune lineage.
Numerous patient-based methods have been proposed to
test for sensitization and irritancy, including corneometry,
transepidermal water loss, quantitative sensory testing, and
thermal sensation tests (Marriott et al., 2005). The lactic acid
(LA) stinging test is also commonly used to determine the
tolerability of sensitive skin to a given chemical (Frosch and
Kligman, 1977). For many decades, alternative endpoints of
skin sensitization and irritancy have utilized animal-based
in vivo assays; however, none of these tests provide a clear
standardized measurable outcome to predict skin reaction,
and they are not compatible with high-throughput testing that
is required by industry.
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This, combined with European Union directives prohibit-
ing the use of animal testing for cosmetics (2003/15/EU,
2010/63/EU, and European Union regulation 1223, 2009),
has seen the development, acceptance, and rapid rise of
nonanimal alternative in vitro assays for skin sensitization
and irritancy. Such methods include protein-binding in-
teractions using the direct peptide reactivity assay (Gerberick
et al., 2004). Current cell-based tests include those using
myeloid cancer cell lines, such as the human cell line acti-
vation test that measures changes in CD86 and CD54
expression in THP-1 monocytes (Ashikaga et al., 2006;
Sakaguchi et al., 2006); U-SENS, based on a similar readout
using U937 cells (Alépée et al., 2015; Piroird et al., 2015);
and those based on monolayer-cultured KC reporter-based
assay systems, including KeratinoSens (Andreas et al., 2011;
Emter et al., 2010) and LuSens (Ramirez et al., 2014), or
secretion of IL-18 (Corsini et al., 2013), some of which have
been accepted by or are in review at the Organisation for
Economic Co-operation and Development as approved
standard tests. An in vitro version of the LA stinging test has
also been developed (Sakka et al., 2018).
However, these tests are based on cells in monoculture,
whereas skin is composed of a stratified squamous epithelium
containing KCs displaying increasing levels of differentiation,
with a granular layer and stratum corneum that play a sig-
nificant role in skin permeability to topically applied com-
pounds. The use of tissue-engineered human skin equivalents
(HSEs) for both skin sensitivity and irritancy aims to overcome
the deficiencies of simple monoculture assays.
Characterization of skin sensitivity and irritancy at the gene
level is rapidly gaining pace and has driven the development
of several gene expression-based assay systems using either
reconstituted human epidermis skin equivalents that consist
solely of a stratified squamous epidermis (Hasan et al., 2019;
Saito et al., 2017) or full-thickness HSE (consisting of both
epidermis and a fibroblast-populated dermis), with SENS-IS
being the most advanced in terms of validation against a
large panel of chemicals (Cottrez et al., 2016). We recently
reported whole genome expression profiles of reconstituted
human epidermis in response to LA, identifying several genes
highly associated with irritancy and sensitization (Hasan
et al., 2019). Here, we report the use of a full-thickness
HSE system based on immortalized skin KCs and show that
a 22-gene panel can discriminate between chemicals known
to act as irritants from those that do not. Moreover, we use
linear discrimination analysis (LDA) to further refine the gene
set for more high-throughput analysis, narrowing the panel
down to seven genes that correctly cluster irritants from
nonirritants.
RESULTS
Histological analysis of human skin and HSEs after treatment
with chemical compounds
LA and other cosmetic compounds—methylparaben (MP),
cocamide diethanolamine (Co-DEA), or cocamide mono-
ethanolamine (Co-MEA)—were applied topically to ex vivo
human skin and HSE for 24 hours. Histological analysis of the
untreated skin and HSE revealed a full-thickness stratified
squamous epithelium with signs of epithelial desquamation
and a dermal fibroblast-populated dermis (Figure 1a and b),
the structure of which was not altered on treatment with the
vehicle control (CON), water (H2O) (Figure 1c and d). In
contrast, LA caused marked disruption to the epidermis in
both skin and HSE in comparison to CON, where extensive
detachment of the epidermis from the basement membrane
Figure 1. Morphological characterization of human skin and HSEs after
topical application of chemical compounds. Representative images of H&E-
stained sections of human skin (left panels) and HSE (right panels) after
exposure to chemical compounds for 24 hours. (a, b) Untreated, (c, d) vehicle
H2O CON, (e, f) LA (5%), (g, h) MP (0.2%), (i, j) Co-DEA (2%), and (k, l) Co-
MEA (2%). Bar ¼ 50 mm; n ¼ 3, with skin from a different donor used in each
independent experiment. Co-DEA, cocamide diethanolamine; Co-MEA,
cocamide monoethanolamine; CON, control; H2O, water; HSE, human skin
equivalent; LA, lactic acid; MP, methylparaben.
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was observed in ex vivo skin but not in HSE. In contrast,
epithelial vacuolation was observed in the stratum spinosum
of HSE, but this was less obvious in ex vivo skin (Figure 1e
and f). Treatment with MP caused no morphological effects in
skin or HSE (Figure 1g and h). Ex vivo skin showed no his-
tological changes on treatment of Co-DEA, whereas HSE
displayed occasional vacuolation in the stratum spinosum
(Figure 1i and j). Treatment of ex vivo skin with Co-MEA
caused epidermal detachment of the basement membrane
in places with occasional epithelial vacuolation, whereas for
HSE, only vacuolation in the stratum spinosum was observed
(Figure 1k and l).
Epithelial integrity of human skin and HSE after incubation
with chemical compounds
In many instances, epithelial vacuolation in response to
chemical stimuli is transient and reversible, and so its pres-
ence may not directly correlate with tissue damage (Shubin
et al., 2016). Therefore, release of lactate dehydrogenase
(LDH) by cells in the skin or HSE was used as a measure of
cellular damage after topical exposure to the compounds for
24 hours. No significant differences in LDH release were
observed for both skin and HSE after treatment with any of
the chemical compounds (Figure 2a and b). Tissue integrity,
measured using transepithelial electrical resistance (TEER),
showed a similar trend with only a significant reduction
observed after treatment with LA (P ¼ 0.005) for human skin.
Treatment with 5% SDS, a detergent known for its epithelial-
disrupting properties, significantly reduced the TEER readings
compared with all other treatments for both human skin and
HSE (P < 0.0001) (Figure 2c and d).
Gene expression profile of human skin and HSE in response
to chemical compounds
Gene expression analysis for a panel of 22 genes previously
associated with a LA response (Hasan et al., 2019) was
performed by qPCR and fold-changes in expression
compared with vehicle-treated CONs (Figure 3). Treatment
of skin with LA revealed a significant fold-increase in AFT3
(P ¼ 0.0027), DDIT (P < 0.0001), F2RL2 (P ¼ 0.0192),
fibronectin gene FN-1 (P < 0.0001), signal transducer and
activator of transcription gene STAT-1 (P ¼ 0.0204),
HMGB2 (P < 0.0001), IL1b (P < 0.0001), IL-6 (P ¼ 0.0009),
MAP3K8 (P ¼ 0.0133), and transit amplifying cell gene
TAC-1 (P < 0.0001), and a fold-decrease in expression
observed for matrix metalloproteinase (MMP) gene MMP-3
(P ¼ 0.0364) compared with CON (Figure 3a). A similar
cohort of genes were also affected when HSEs were treated
with LA with a significant fold-increase observed for ATF3
(P ¼ 0.0235), DDIT (P ¼ 0.0214), fibronectin gene FN-1
(P ¼ 0.0270), signal transducer and activator of transcription
gene STAT-1 (P ¼ 0.0004), heat shock protein gene HSP1A
(P ¼ 0.0050), MAP3K8 (P ¼ 0.0151), transit amplifying cell
gene TAC-1 (P ¼ 0.0143) and SERPINE1 (P ¼ 0.0091). In
contrast to skin, MMP-3 (P ¼ 0.0003) expression was
significantly increased and CALCA (P < 0.0001) was
significantly decreased in HSEs (Figure 3b). Exact fold-
changes in gene expression for skin and HSE are provided
in Tables 1 and 2.
Treatment of skin and HSE with MP revealed few changes,
with a significant fold-decrease in MAP3K8 (P ¼ 0.0224) for
skin (Figure 3c) and increased expression of IL1b (P ¼
0.0225) and decreased expression of CALCA (P < 0.0001) for
HSE compared with CON (Figure 3d). Treatment of skin with
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Figure 2. Epithelial integrity after topical exposure to chemical compounds. LDH release and TEER measurements for (a, c) human skin and (b, d) HSEs
after exposure to compounds for 24 hours: LA (5%), MP (0.2%), Co-DEA (2%), Co-MEA (2%), and SDS (5%). Data presented as mean  SD. **P <0.01 and
****P <0.0001 as analyzed by ordinary one-way ANOVA with Dunnett’s multiple comparison compared with vehicle CON; n ¼ 3, with skin from a different
donor used in each independent experiment. Co-DEA, cocamide diethanolamine; Co-MEA, cocamide monoethanolamine; CON, control; HSE, human skin
equivalent; LA, lactic acid; LDH, lactate dehydrogenase; MP, methylparaben; TEER, transepithelial electrical resistance.
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Co-DEA stimulated increased expression of F2RL2 (P ¼
0.0012) and HMGB2 (P ¼ 0.0031) with fold-decreases
observed for MMP-3 (P ¼ 0.0031) (Figure 3e) in skin,
whereas Co-DEA increased expression of DDIT (P ¼ 0.0072)
and heat shock protein gene HSP1A (P ¼ 0.0065) in HSE and
decreased expression of CALCA (P < 0.0001) for HSE
compared with CON (Figure 3f). Treatment of tissues with
Co-MEA caused the fewest changes in gene expression, with
significant increased expression of IL1a (P ¼ 0.0474) and
again a fold-decrease in MMP-3 (P ¼ 0.0010) for skin
(Figure 3g) and only decreased expression of CALCA (P <







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3. RT-qPCR expression data for 22 genes of interest after treatment with chemical compounds. Fold-change differences in gene expression for human
skin (left panels) and HSE (right panels) in response to exposure to chemical compounds for 24 hours. (a, b) LA (5%), (c, d) MP (0.2%), (e, f) Co-DEA (2%), and (g,
h) Co-MEA (2%). The Ct of each test gene was normalized against the U6 reference gene, and then fold-changes in gene expression relative to the H2O-treated
CON group were calculated using the formula 2-DDCt. Data are presented as mean  SD. *P ¼0.05, **P <0.01, ***P <0.001 and ****P <0.0001. Genes were
analyzed by ordinary one-way ANOVA for each treatment with Dunnett’s multiple post-hoc comparison test compared with vehicle control; n ¼ 3, with skin
from a different donor used in each independent experiment. Co-DEA, cocamide diethanolamine; Co-MEA, cocamide monoethanolamine; CON, control; FN,
fibronectin; H2O, water; HSE, human skin equivalent; HSP, heat shock protein; LA, lactic acid; MMP, matrix metalloproteinase; MP, methylparaben; STAT, signal
transducer and activator of transcription; TAC, transit amplifying cell.
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Multivariate analysis of chemical compound gene signatures
in human skin and HSE
Hierarchical gene cluster analysis of the 22-gene panel
showed that gene expression for skin and HSE clustered
separately and distinguishable from each other, except for
two of the three Co-DEAetreated HSE samples that clustered
with skin. All other treatments displayed gene profiles that
were distinguishable from each other based on hierarchical
analysis; the exception was for LA-treated skin where one of
the samples displaying high levels of MYC and TRPA1 was
unclustered (Figure 4a). Principal component analysis (PCA)
showed that LA-treated skin and HSE clustered away from the
other chemical compounds, indicating that the 22-gene
panel differentiates between irritant and nonirritant com-
pounds (Figure 4b). The nonirritants Co-DEA, Co-MEA, and
MP clustered tightly together with overlapping prediction
ellipses. In contrast, LA-treated skin and HSE clustered
separately, suggesting that LA activates similar but slightly
distinct gene responses in skin compared with HSE
(Figure 4b). Based on these results, HSEs were used in all
subsequent experiments.
Differences in HSE gene expression profiles discriminating
sensitizing compounds
To further explore if the 22-gene panel can be used to
discriminate irritant compounds, we expanded the test
chemical set to include cinnamaldehyde (CA) and capsaicin
(CAP) (classical irritants) and neutralized LA (N-LA) (a
nonirritant). Histological analysis revealed signs of epithelial
vacuolation in the basal epithelium of CA-treated HSE and
within the stratum spinosum of CAP-treated HSE that was
absent in both N-LAetreated and CON HSE (Figure 5a).
Indeed, in this instance, both CA and CAP induced significant
(P < 0.01) cytotoxicity and decreased tissue integrity (P 
0.01) compared with treatment with vehicle CON when
assessed by LDH release and TEER analysis, respectively,
whereas treatment with N-LA had no effect (Figure 5b and c).
Hierarchical cluster analysis of the gene panel showed that
chemical irritants generally clustered together, with CA and
CAP being closely associated, displaying increased gene
expression in a number of common genes (Figure 6a and
Table 2). PCA of gene expression profiles exemplified this
with Co-DEA, Co-MEA, MP, and N-LA displaying overlapping
prediction ellipses, whereas LA-treated HSEs present as a
separate cluster (Figure 6b), suggesting that not only can the
22-gene panel distinguish irritant from nonirritant com-
pounds but also that it has the potential to differentiate be-
tween different chemical classes of irritant compounds.
LDA
A 22-gene set is a relatively large panel to routinely examine
the potential of any given compound to induce irritation. It is
possible that a number of genes in the panel are redundant or
contribute little to the overall cluster analysis and that a
Table 1. RT-qPCR Expression Data for 22 Genes of Interest after Exposure of Human Skin with Chemical
Compounds
Gene LA MP Co-DEA Co-MEA
ATF3 13.93  7.291 0.67  0.27 4.77  1.39 3.43  1.01
CYR61 23.53  29.24 1.81  1.06 2.05  0.47 1.05  0.10
DDIT 9.49  3.131 1.11  1.09 0.86  0.23 0.85  0.16
F2RL2 11.61  6.331 1.18  0.65 17.19  5.421 0.46  0.09
FN-1 33.94  7.191 3.12  2.72 4.25  6.05 1.13  0.85
STAT-1 5.43  3.511 0.91  0.28 0.86  0.23 0.85  0.16
HMGB2 10.18  2.701 1.76  1.10 6.37  1.031 2.46  0.70
HSP1A 2.55  0.42 0.61  0.10 9.32  8.15 6.97  1.70
IL-1A 1.85  0.83 0.75  0.32 2.29  1.22 28.11  25.351
IL-1B 12.21  3.491 1.65  0.52 1.83  0.92 0.88  0.37
IL-6 6.96  2.671 1.00  0.32 0.86  0.18 1.41  1.24
MAP3K8 1.86  0.341 0.21  0.232 1.18  0.07 0.51  0.47
MYC 598.60  838.8 1.36  0.54 1.2  0.63 0.82  0.30
TAC-1 6.18  0.891 1.44  0.88 1.54  0.46 1.69  0.72
PTGS2 2.91  1.84 1.27  0.54 0.89  0.23 3.1  1.84
TRPV1 3.78  2.97 1.41  0.19 0.51  0.62 1.29  0.24
SERPINE-1 6.48  5.13 0.58  0.39 1.23  1.04 0.92  0.81
TRPA1 18.49  21.49 2.51  0.45 4.49  1.50 0.03  0.02
MMP-3 0.45  0.342 0.59  0.32 0.16  0.132 0.02  0.032
TRPV3 1.65  0.90 1.84  0.75 0.35  0.05 0.53  0.44
PMAIP 2.08  0.36 1.63  0.68 3.67  3.43 2.54  1.00
CALCA 1.39  1.22 1.43  1.13 0.18  0.24 1.28  0.38
Abbreviations: Co-DEA, cocamide diethanolamine; Co-MEA, cocamide monoethanolamine; CON, control; FN, fibronectin; HSP, heat shock protein; LA,
lactic acid; MMP, matrix metalloproteinase; MP, methylparaben; STAT, signal transducer and activator of transcription; TAC, transit amplifying cell.
Gene expression fold-change for human skin in response to exposure to chemical compounds for 24 hours—LA (5%), MP (0.2%), Co-DEA (2%), and Co-
MEA (2%)—compared with relative CON samples. Data are expressed as fold-change relative to housekeeping gene U6. Data presented as mean  SD; n ¼
3 from three different donors.
1Genes with statistically significant fold-increase.
2Genes with statistically significant fold-decrease.
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smaller panel could be used with similar success. We used
LDA to interrogate the gene panel to define a reduced cohort
of genes with maintained effectiveness at identifying irritation
potential. LDA identified seven genes with coefficients above
0.5 (IL-6, PTGS2, ATF3, TRPV3, MAP3K8, HMGB2, and
MMP-3) (Table 3) that when reanalyzed for their hierarchical
clustering profiles (Figure 7a) and PCA (Figure 7b), retained
their ability to discriminate irritant from nonirritant
chemicals.
DISCUSSION
Skin irritation or sensitivity has been attributed to the release
of mediators that may instigate inflammation, disruption of
the stratum corneum, and/or induction of neuronal hyper-
sensitivity (Misery et al., 2017). Consumers of dermatological
products require adequate protection against chemicals that
have the potential to cause adverse skin reaction, and this,
combined with legislative changes, has encouraged re-
searchers to develop more robust and standardized in vitro
skin assays. Using microarray technology, our previous work
on reconstituted HSE identified a 25-gene panel that was
associated with an LA-induced skin reaction (Hasan et al.,
2019). Reconstituted HSEs are comprised solely of skin KCs
and so lack the paracrine interplay with dermal fibroblasts
that also contributes to a skin reaction. Therefore, in this
study, we used full-thickness HSE as a more representative
model. Studies with similar experimental setups using normal
human skin KCs have found significant donor-to-donor vari-
ability, with disparity in HSE responses dependent on the
batch of KCs used (Cottrez et al., 2016). To minimize this
experimental variation, we have used telomerase reverse
transcriptase (TERT)-immortalized skin KCs to reduce genetic
background and to assist in assay transferability, an important
consideration if the technology is to be adopted by other
laboratories.
As a proof-of-principle investigation, we initially examined
the response of HSE to 5% LA, a known irritant that induces
an inflammatory and stress-response pathway (Hasan et al.,
2019; Rendl et al., 2001). We also tested the chemical pre-
servative MPand Co-DEA and Co-MEA, surfactants present in
many cosmetic products, and compared these with freshly
excised human skin treated with the same chemicals. We
chose concentrations of MP, Co-DEA, and Co-MEA that are
known to be nonirritant so that differences between irritant
and nonirritant agents could be assessed.
Although histological examination showed signs of
epithelial vacuolation in some treated samples, LDH and
TEER analysis suggested that this was not translated to
epithelial cell damage. Hierarchical clustering of gene
expression data followed by PCA revealed that this 22-gene
panel could effectively discriminate between LA and the
nonirritants MP, Co-DEA, and Co-MEA. The nonirritants
Table 2. RT-qPCR Expression Data for 22 Genes of Interest after Exposure of HSEs with Chemical Compounds
Gene LA CAP CA N-LA MP Co-DEA Co-MEA
ATF3 3.06  1.631 8.88  2.111 4.09  1.141 0.89  0.05 0.37  0.17 0.40  0.29 0.33  0.29
CYR61 11.47  13.06 2.76  0.831 1.77  0.95 0.15  0.10 1.34  0.46 1.63  1.81 1.48  0.77
DDIT 4.07  2.131 8.67  3.961 7.42  2.181 5.02  1.01 1.13  0.43 4.69  1.071 1.19  0.49
F2RL2 0.82  0.49 1.58  0.38 0.93  0.20 0.37  0.46 1.80  2.05 0.40  0.34 0.15  0.17
FN-1 4.27  2.241 26.87  8.311 50.90  7.741 18.12  5.651 1.66  0.80 1.59  1.11 0.52  0.80
STAT-1 18.40  3.501 6.19  2.321 4.98  1.20 4.67  2.38 6.78  6.89 0.73  0.10 0.67  0.27
HMGB2 3.65  2.46 1.83  0.30 1.99  0.90 1.12  0.16 0.39  0.60 0.96  0.79 1.46  1.67
HSP1A 8.12  4.281 2,160,476  3,741,437 158.8  65.46 120.60  81.85 0.17  0.26 7.83  1.371 0.36 0.14
IL-1A 1.02  0.91 0.92  0.16 0.61  0.51 1.59  0.34 0.59  0.18 1.22  0.39 0.40  0.30
IL-1B 4.03  3.4 0.16  0.072 0.99  0.35 1.20  0.30 9.79  6.151 1.32  1.22 0.04  0.02
IL-6 3.22  2.50 0.72  0.92 0.61  0.26 0.70  0.61 1.13  0.70 2.12  0.80 1.94  3.16
MAP3K8 3.23  1.221 0.66  0.36 3.35  1.691 0.62  0.23 0.80  0.69 0.65  0.94 0.11  0.09
MYC 15.42  13.84 7.29  2.441 5.31  3.00 1.88  1.01 1.28  0.30 0.80  0.73 0.39  0.43
TAC-1 3.39  1.511 21.99  10.751 4.45  0.76 0.87  0.12 0.57  0.65 0.87  0.68 0.16  0.14
PTGS2 2.06  0.56 3.73 1.51 2.42  0.76 0.72  0.62 0.62  0.54 1.13  1.18 0.23 0.30
TRPV1 0.89  1.54 0.37  0.65 1.62  0.45 2.84  1.38 0.32  0.56 0.193  0.33 0.0001  2.309e-005
SERPINE-1 3.83  1.881 3.74  2.061 2.02  0.96 1.39  0.46 0.78  0.36 1.47  0.16 0.25  0.42
TRPA1 1.93  0.93 2.97  2.51 2.28  0.57 1.03  0.05 2.03  2.30 2.14  1.30 0.84  0.88
MMP-3 9.19  2.821 0.95  0.85 0.74  0.68 0.18  0.30 2.23  1.46 1.63  1.60 0.05  0.03
TRPV3 1.24  1.10 2.86  0.991 1.91  0.17 0.31  0.44 0.20  0.35 0.09  0.04 0.08  0.13
PMAIP 1.46  1.21 2.34  0.46 2.45  0.86 1.10  0.77 0.78  0.43 1.14  0.94 0.45  0.41
CALCA 0.029  0.052 9.34  10.24 5.22  0.58 2.44  1.58 0.002  0.0042 0.002  0.0042 0.003  0.0052
Abbreviations: CA, cinnamaldehyde; CAP, capsaicin; Co-DEA, cocamide diethanolamine; Co-MEA, cocamide monoethanolamine; CON, control; FN,
fibronectin; HSE, human skin equivalent; HSP, heat shock protein; LA, lactic acid; MMP, matrix metalloproteinase; MP, methylparaben; N-LA, neutralized
lactic acid; STAT, signal transducer and activator of transcription; TAC, transit amplifying cell.
Gene expression fold-change in response to exposure to chemical compounds for 24 hours— LA (5%), MP (0.2%), Co-DEA (2%), Co-MEA (2%), N-LA, CA
(3%), and CAP (0.1%)—compared with relative CON samples. Data are expressed as fold-change relative to housekeeping gene U6. Data presented as
mean  SD. Genes were analyzed by ordinary one-way ANOVA for each treatment with Dunnett’s multiple comparison compared with vehicle control;
n ¼ 3.
1Genes with statistically significant fold-increase.
2Genes with statistically significant fold-decrease.
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clustered closely together for both HSE and ex vivo skin,
whereas gene responses to LA clustered into two distinct
clusters, one for HSE and one for skin. This is likely because
of LA interacting with a more extensive repertoire of cell
types that are present within ex vivo skin (vascular, nerve,
immune cell) as compared with HSE that are composed of
just KCs and fibroblasts. For example, upregulation of genes
for TRPA1 and TRPV1, which have previously been associ-
ated with sensory neuron activation in the epidermis (Nielsen
et al., 2018), was observed in ex vivo skin but not in HSE.
Nevertheless, HSE composed of KCs and fibroblasts was still
proficient at discriminating between the two classes of
compounds, suggesting that this simplified in vitro skin
model still has the power to discriminate between irritant and
nonirritant chemicals. Addition of N-LA to HSEs reversed the
gene expression profile from an irritant to a nonirritant
phenotype that clustered with MP, Co-DEA, and Co-MEA by
PCA, reinforcing the specificity of the gene panel and the
ability of HSE to detect and respond to changes in Hþ ions. To
underline this, stimulation of HSE with CA and CAP induced
epithelial damage and clustered as irritants but with a distinct
gene profile to LA, reflecting the ability of these molecules to
signal via different pathways.
Although made up of entirely different genes apart from
MMP-3 and IL1a, the discriminatory power of our 22-gene
signature panel reflects closely to that of the 38 REDOX
and inflammatory gene panel used in the SENS-IS assay
(Cottrez et al., 2016). This is quite remarkable given the fact
that our 22-gene set was derived using an unbiased micro-
array experimental approach (Hasan et al., 2019), whereas
the SENS-IS 38-gene panel was chosen from an initial 900
gene set identified from data mining and review of the pub-
lished literature from in vivo data from murine and human
studies (Cottrez et al., 2015). The SENS-IS assay has been
rigorously tested against more than 150 chemical com-


































































Figure 4. Multivariate analysis of
chemical stimulation on gene
signatures in skin and HSEs.
Unsupervised hierarchical clustering
of gene expression data for 22 genes
after treatment with chemicals. In the
heatmap visualization, each gene is
represented by a single row and each
chemical, a single column. (a) Red
indicates increased fold-change in
gene expression, whereas dark blue
indicates decreased fold-change gene
expression. Unsupervised hierarchical
cluster analysis was performed using
correlation distance and average
linkage. (b) PCA representing gene
expression profiles for skin (square)
and HSE (circle). The score plot
displaying PC1 and PC2 explains
37.3% and 14.1% of the total
variance, respectively, after exposure.
Prediction ellipses have a probability
of 0.95 that a new observation from
the same group will fall within the
ellipse. Single-value decomposition
with imputation was used to calculate
the PC. Co-DEA, cocamide
diethanolamine; Co-MEA, cocamide
monoethanolamine; FN, fibronectin;
HSE, human skin equivalent; HSP,
heat shock protein; LA, lactic acid;
MMP, matrix metalloproteinase; MP,
methylparaben; PC, principal
component; PCA, principal
component analysis; STAT, signal
transducer and activator of
transcription; TAC, transit amplifying
cell.
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any seven positively upregulated genes from the 38-gene
panel, with high specificity, sensitivity, and accuracy re-
ported (Cottrez et al., 2016). However, the use of large gene
signature sets is cumbersome, and they do not lend them-
selves to easy analysis and high-throughput testing. Various
integrated machine learning and bioinformatics approaches
have been used to improve the prediction of toxicology and
adverse reaction assays (Del Bufalo et al., 2018; Patlewicz
et al., 2014). Here, we used LDA to refine our panel to
identify the genes that contribute most to define irritation and
found that a panel of just seven genes (ATF3, MAP3K8, IL-6,
PTGS2, TRPV3, HMGB2, and MMP-3) were still
discriminatory based on PCA. These genes cover a range of
pathways, including inflammation, cell viability, damage,
and extracellular remodeling, and have been identified in
previous reports examining skin irritation or sensitivity.
ATF3 is a member of the CREB family of transcription
factors whose expression is induced in response to cell stress,
and on activation, ATF3 promotes gene transcription of fac-
tors that regulate metabolism, apoptosis, and inflammation
(Thompson et al., 2009). Previous studies have shown
increased ATF3 gene expression in monolayer cultures of
skin KCs in response to chemical insult and UVR (Schaper-
Gerhardt et al., 2018), and increased protein levels have
been observed in the epidermis of patients with the inflam-
matory skin disease erythema multiforme (Pollack et al.,
2010). Moreover, ATF3 was identified as a key upregulated
gene in an in vitro reconstituted epidermis-only HSE in
response to a number of skin irritants (Saito et al., 2013) and
in gene dysregulation network analyses for genes implicated
in toxicity and sensitization (Pronk et al., 2013), implicating
this transcription factor in regulating skin immune responses
to irritants. Likewise, MAP3K8 is a key regulator of the innate
immune response (Arthur and Ley, 2013) and is responsible
for activation of extracellular signaleregulated kinase 1/2 and
p38 MAPK, whose expression have been implicated in skin
inflammation in response to irritants in in vivo experimental
models (Pastore et al., 2005) and in reconstituted HSE
(Frankart et al., 2012). In addition, on cell stress, MAPK in-
creases the expression of ATF3 in skin KCs (Harper et al.,
2005), thereby linking these two transcription factors.
Along with these two inflammatory-associated transcrip-
tion factors, gene expression of the inflammatory mediators
IL-6 and PTGS2 (often termed cyclooxygenase-2) was also
identified. Increased gene expression of IL-6 was detected in
human skin in response to the irritant nonanoic acid using
microarray analysis (Clemmensen et al., 2010). Elevated IL-6
expression has also been detected in two-dimensional
monolayers of cultured primary skin KCs, HaCaT cells, and
dermal fibroblasts (Jung et al., 2016; Terunuma et al., 2001).
Tsai et al. (2016) detected elevated secretion of IL-6 using a
full-thickness HSE constructed of HaCaT KCs in response to a
number of skin irritants, and Schmalz et al. (1998) observed
similar findings when HSEs constructed of primary cells were
incubated with metal-containing ceramics, whereas Bock
et al. (2018) found that IL-6 secretion was only increased
when MUTZ-3 Langerhans-like cells were incorporated into
their HSE on stimulation with irritants. IL-6 was also
dramatically increased in a dermal fibroblast onlyepopulated
three-dimensional model in response to cadmium chloride
and lauryl sulfate (Augustin and Damour, 1995), suggesting
that fibroblasts may be an important source of IL-6 in skin.
PTGS2 gives rise to PGs, molecules that are also involved
in inflammation and can promote KC proliferation, aiding
wound healing (Sato et al., 1997). Increased PTGS2 gene
expression was previously detected in human skin samples
exposed to the known irritants lauryl sulfate and nanonic acid
(Clemmensen et al., 2010). Increased PTGS2 expression has
also been observed in the suprabasal epidermal region of
guinea pig skin in response to iodide (Nyska et al., 2001) and
in murine epidermis in retinol- or benzalkonium





















































Figure 5. Epithelial integrity of HSEs after topical exposure to chemical
compounds. (a) Representative images of H&E-stained sections of HSEs after
exposure to chemical compounds for 24 hours: N-LA, CAP (0.1%), and CA
(3%). Bar ¼ 50 mm. (b) LDH release and (c) TEER measurements for HSEs after
exposure to compounds for 24 hours: N-LA, CA (3%), CAP (0.1%), and SDS
(5%). Data presented as mean  SD. *P <0.05, **P <0.001 and ***P <0.001
as analyzed by ordinary one-way ANOVA with Dunnett’s multiple
comparison compared with vehicle CON; n ¼ 3. CA, cinnamaldehyde; CAP,
capsaicin; CON, control; HSE, human skin equivalent; LDH, lactate
dehydrogenase; N-LA, neutralized lactic acid; TEER, transepithelial electrical
resistance.
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using a full-thickness HSE, Black et al. (2010a, 2010b)
detected increased expression of PTGS2, also in the supra-
basal region, in response to the vesicant 2-chloroethyl ethyl
sulfide, and this appears to be mediated by activation of
MAPK. Dermal fibroblasts were also found to secrete PGs in a
PTGS2-dependent manner in both a three-dimensional
fibroblast-containing collagen matrix and a murine model
of irritant contact dermatitis (Saalbach et al., 2015; Sato et al.,
1997). Taken together, these data provide strong evidence for
the role of inflammatory mediates in the response to irritants
and their usefulness in predictive irritant screening.
Our seven-gene panel also includes TRPV3, a receptor
expressed by epidermal KCs with barrier function properties
(Cheng et al., 2010; Peier et al., 2002). Several lines of
evidence link TRPV3 with skin irritation. A number of plant-
derived molecules containing known irritants, such as
carvacrol, eugenol, and thymol, have been shown to activate
KC-expressed TRPV3 (Xu et al., 2006). Moreover, activation
of TRPV3 by a-hydroxyl acidecontaining compounds causes
excessive KC exfoliation that is linked with skin irritation
(Cao et al., 2012), and ablation of TRPV3 attenuated skin
lesions in mice (Qu et al., 2019).
HMGB2 is a DNA-binding protein that facilitates the ac-
tivity of transcription factors, although it can be released from
necrotic cells where it has been shown to have a role in
inflammation (Taniguchi et al., 2018). We previously showed
that HMGB2 is upregulated in reconstituted HSE when sub-






































































Figure 6. Multivariate analysis of
HSEs treated with known irritants and
nonirritants. (a) Hierarchical
clustering of gene expression data for
22 genes after treatment with
chemicals with heatmap visualization.
Each gene is represented by a single
row, and each chemical compound
treatment is represented by a single
column. Red indicates increased fold-
change in gene expression, whereas
dark blue indicates decreased fold-
change gene expression. Hierarchical
cluster analysis was performed using
correlation distance and average
linkage. (b) PCA representing gene
expression profiles for HSE. The score
plot displays PC1 and PC2 that
explains 31.6% and 16.6% of the total
variance, respectively, after exposure
to chemicals. Prediction ellipses
included with a probability of 0.95
that a new observation from the same
group will fall inside the ellipse.
Single-value decomposition with
imputation was used to calculate PCs.




HSE, human skin equivalent; HSP,
heat shock protein; LA, lactic acid;
MMP, matrix metalloproteinase; MP,
methylparaben; N-LA, neutralized
lactic acid; PC, principal component;
PCA, principal component analysis;
STAT, signal transducer and activator
of transcription; TAC, transit
amplifying cell.
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studies that examine its role in the skin, evidence from
cisplatin- and benzopyrene-induced skin cytotoxicity exper-
iments suggest that HMGB2 released from necrotic KCs
triggers an immune response (Sharma et al., 2008), suggest-
ing that a similar mechanism may occur in response to skin
irritants.
MMP-3 (or stromelysin-1) is a protease with a broad
specificity for many connective tissue extracellular matrix
proteins and has been implicated in playing a role in skin
pathology. For instance, MMP-3edeficient mice displayed
an impaired response to topical treatment with the potent
irritant dinitrofluorobenzene (Wang et al., 1999).
Clemmensen et al. (2010) observed epidermal expression
of MMP-3 in experimental irritant contact dermatitis in
human skin and suggested that secretion of this protease
may release GFs that are sequestered in the extracellular
matrix as part of a tissue repair process. The gene transcript
for MMP-3 has been detected previously by us and others
on analysis of either reconstituted human epidermis or full-
thickness HSE when these models were treated with
several irritants (Cottrez et al., 2016, 2015; Hasan et al.,
2019; Petry et al., 2018), underscoring its significance as
a marker of skin irritation.
Our data provide good evidence that HSEs based on KCs
and fibroblasts alone have the ability to discriminate between
irritant and nonirritant chemicals. However, skin is composed
of many different cell types with neuronal and immune
components, in particular, known to markedly influence skin
irritation and sensitivity reactions. Indeed, the presence of
neuronal and immune cells in ex vivo skin is the likely reason
for the difference we observed in gene expression profiles of
skin and HSE toward LA. Although the HSE used in this study
has discriminatory power, the lack of a neuronal and immune
component highlights its limitations. The move toward
advanced HSE is well underway, with published reports of
innervated skin equivalents, although these in vitro models
have used rodent sensory neurons in combination with hu-
man cells (Blais et al., 2014; Cadau et al., 2015; Lebonvallet
et al., 2012), which raises concerns about cross-species
paracrine signaling and the use of whole tissue human
gene expression profiling as an assay readout. Advancement
in the use of human induced pluripotent stem cells may
circumvent these issues (Muller et al., 2018). Likewise, HSEs
containing Langerhans cells have been developed
(Ouwehand et al., 2012, 2011b) and have been shown to
respond to chemical stimulation (Bock et al., 2018;
Ouwehand et al., 2011a). Combining all these cell types into
a reproducible HSE that will respond to chemical insult in a
standardized manner and that can be translated to industry
will be challenging, although not impossible.
In conclusion, the expression of a seven-gene panel in
HSE, based on immortalized KCs, in combination with
multivariate statistical approaches shows enhanced confi-
dence in the discrimination of skin irritants from nonirritants.
This reproducible human in vitro assay offers potential in
high-throughput compound assessment, but further testing of
a larger chemical set is required to fully evaluate its predic-
tive power.
MATERIALS AND METHODS
All reagents were purchased from Sigma-Aldrich (Gillingham,
United Kingdom) and used as per the manufacturers’ instructions
unless otherwise stated.
Cell culture
TERT-immortalized human skin KCs (N/TERT-1; from Prof. Rhein-
wald) (Dickson et al., 2000) were cultured at low density in KC
serum-free media (Thermo Fisher Scientific, Waltham, MA) supple-
mented with 25 mg/ml bovine pituitary extract, 0.2 ng/ml EGF, and
0.3 mM calcium chloride (total calcium ion concentration, 0.4 mM).
Human dermal fibroblasts (HDFs) were isolated from skin biopsies
obtained from the breast tissue of patients undergoing surgery with
written, informed consent (ethical approval 09/H1308/66). Biopsies
were incubated in 0.1% (w/v) trypsin solution supplemented with
100 IU/ml penicillin, 100 mg/ml streptomycin, and 0.625 mg/ml
amphotericin B overnight at 4 C. After enzymatic digestion, HDFs
were isolated from the connective tissue by fine mincing followed by
treatment with 0.25% (w/v) collagenase for 5 hours at 37 C then
collected by centrifugation and cultured in DMEM supplemented
with 10% v/v fetal bovine serum, 100 IU/ml penicillin, 100 mg/ml
streptomycin, and 2 mM L-glutamine. Cells were incubated at 37 C
in a 5% carbon dioxide humidified incubator, medium changed
every 3 days, passaged when 80% confluent, and used up to
passage 5.
Generation of tissue-engineered HSEs
HSEs were constructed using N/TERT-1 as previously described
(Dickson et al., 2000). In brief, rat tail collagen (5 mg/ml) was
combined with 8% (v/v) fetal bovine serum, DMEM (10), 2 mM L-
glutamine, and reconstitution buffer (2.2% sodium bicarbonate,
4.8% HEPES, 0.25% sodium hydroxide in distilled H2O) and the pH

























Abbreviations: FN, fibronectin; HSP, heat shock protein; LDA, linear
discrimination analysis; MMP, matrix metalloproteinase; STAT, signal
transducer and activator of transcription; TAC, transit amplifying cell.
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Figure 7. Multivariate analysis and machine learning approach to identify irritant gene signature in HSEs. (a) LDA was performed and identified seven genes
with coefficients above 0.5 (IL-6, PTGS2, ATF3, TRPV3, MAP3K8, HMGB2, and MMP-3). Hierarchical clustering of gene expression data for the seven genes of
interest after treatment with chemical compounds is shown with heatmap visualization. Each gene is represented by a single row, and each chemical compound
treatment is represented by a single column. Red indicates increased fold-change in gene expression, whereas dark blue indicates decreased fold-change gene
expression. (b) PCA plot representing gene expression profiles for HSE. PC1 indicates 42.8% and PC2 indicates 24.9% of the total variance after exposure to
chemical compounds. Prediction ellipses included with a probability of 0.95 that a new observation from the same group will fall inside the ellipse. Single-value
decomposition with imputation was used to calculate PCs. CA, cinnamaldehyde; CAP, capsaicin; Co-DEA, cocamide diethanolamine; Co-MEA, cocamide
monoethanolamine; HSE, human skin equivalent; LA, lactic acid; LDA, linear discrimination analysis; MMP, matrix metalloproteinase; MP, methylparaben; N-
LA, neutralized lactic acid; PC, principal component; PCA, principal component analysis.
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adjusted to 7.4 with 2 M sodium hydroxide. HDFs (1.5  105 per
model) were added to the collagen mixture before transferring into
12-well translucent transwell inserts with 0.4 mm pores (Millipore,
Burlington, MA) and allowed to set in a humidified atmosphere at 37
C. Once set, 5 ml HDF culture media was added to the well and
500 ml onto the surface of the collagen and incubated for 24 hours at
37 C. Next, 2.5  105 N/TERT-1 cells were seeded on the collagen
surface and cultured submerged in medium for 2 days, after which
HSEs were raised to an air-to-liquid interface and further cultured for
14 days, changing the medium every other day.
Ex vivo skin and HSE stimulation with chemical compounds
Skin explants from the breast tissue of independent donors were
received from the theater in transport medium (DMEM with antibi-
otics), prepared by removing subdermal tissue, washed in PBS, and
then used immediately in experiments. A 10-mm punch biopsy was
taken and placed into a 0.4-mm pore transwell insert, and HDF
culture media was added to the well underneath. A total of 50 ml of
chemical compound was added to the surface of the ex vivo skin or
HSE and incubated for 24 hours at 37 C. Chemicals tested were LA
(5% v/v), MP (methyl-4-hydroxybenzoate, 0.2% w/v), Co-DEA (2%
v/v), Co-MEA (2% v/v), CAP (0.1% w/v), and CA (3% v/v). Chemicals
were made up in H2O, which was also used as a vehicle CON. A
skin biopsy from a different donor was used in each experiment, and
each experiment was performed at least three times.
LDH release assay
Cell damage was analyzed by measuring the release of LDH into the
culture medium using a CytoTox96 enzyme assay kit as described in
the manufacturer’s instructions (Promega, Madison, WI) as previ-
ously described (Jennings et al., 2016). Disruption of the epithelium
using 5% v/v SDS was used as a positive CON.
TEER
Tissue integrity was assessed by measuring TEER using an EVOM2
voltmeter (World Precicion Instruments, Madison, WI) at three lo-
cations per model, and the average of these values was calculated. A
blank resistance measurement of the insert plus PBS was also
measured for preconditioning. The following equation was used to
measure TEER as previously described (Buchert et al., 2012): TEER
Reported ¼ Resistance (U)  Effective Membrane (cm2).
RNA isolation
Skin and HSEs were washed with PBS before incubation with 15 U
dispase for 2 hours at 37 oC with frequent gentle mixing. The
enzymatic reaction was stopped with PBS before centrifugation at
8,000g for 3 minutes, followed by further washes with PBS. Tri-
reagent (Thermo Fisher Scientific) (300 ml) was added to the cell
pellet and samples centrifuged at 8,000g for 3 minutes. The RNA-
containing supernatant was removed, and the RNA was purified
using RNeasy (Qiagen, Hilden, Germany), according to the manu-
facturer’s instruction. Total RNA (100 ng) was reverse transcribed
using a high-capacity cDNA reverse transcription kit (Thermo Fisher
Scientific), according to the manufacturer’s instructions.
qPCR
qPCR was performed using TaqMan gene expression assays as fol-
lows: 0.5 ml cDNA was amplified using 5 ml master-mixture, 3.5 ml
nuclease-free H2O, and 0.5 ml TaqMan gene probe (FAM); 0.5 ml b2-
microglobulin (VIC) was used as a reference CON (Thermo Fisher
Scientific). Reactions were performed using thermal cycles of 50 C
(2 minutes) and 95 C (10 minutes), then 40 cycles of 15 seconds at
95 C, followed by 1 minute at 60 C. The threshold cycle was
normalized against the reference gene and then fold-changes in
expression relative to the H2O-treated CON group were calculated
using the formula 2-DDCt (Livak and Schmittgen, 2001).
Histological analysis
Skin and HSEs were fixed with 10% v/v neutral-buffered formalin;
alcohol-processed, paraffin waxeembedded, 6-mm sections cut us-
ing a microtome; and sections stained with H&E. Slides were
mounted with distyrene-polystrene xylene and imaged by light
microscopy.
Data analysis
All data are presented as mean  SD unless otherwise stated, with
all experimental repeats clearly stated. Data sets were checked for
normality using the Shapiro-Wilk test. Parametric data was analyzed
by ordinary one-way ANOVA with Dunnett’s multiple post-hoc test
when comparing treatments to H2O vehicle-treated CONs or Tukey’s
post-hoc test for multiple group comparisons, and differences were
considered significant when P < 0.05. Statistical analysis was per-
formed using GraphPad prism version 9.0 (GraphPad Software,
San Diego, CA). Gene expression analysis was subjected to unsu-
pervised hierarchical gene cluster analysis, and heatmap generation
and PCA were conducted using Clustvis web tool (biit.cs.ut.ee/
clustvis/). LDA was accomplished using RStudio (rstudio.com) along
with R-package (https://cran.r-project.org/web/packages/MASS/
index.html). A Github repository containing data analysis is avail-
able (Sting_predict).
Data availability statement
No datasets were generated or analyzed during this study.
ORCIDs
Amy L. Harding: https://orcid.org/0000-0003-3570-9338
Craig Murdoch: https://orcid.org/0000-0001-9724-122X
Simon Danby: https://orcid.org/0000-0001-7363-140X





Helen E. Colley: https://orcid.org/0000-0003-0053-7468
AUTHOR CONTRIBUTIONS
Conceptualization: MZH, HEC, CM, SD; Formal Analysis: ALH, RT; Investi-
gation: ALH, RT; Methodology: ALH, HEC, SD, CM; Project Administration:
HEC, MZH, TF, HN; Resources: SH; Software: RT; Supervision: HEC; Visu-
alization: ALH; Writing - Original Draft Preparation: ALH, CM, HEC; Writing
- Review and Editing: ALH, CM, HEC, SD, MZH
ACKNOWLEDGMENTS
We would like to thank E. Chambers and M. Dunning at The Sheffield Bio-
informatics Core Facility, The University of Sheffield (United Kingdom) for
their assistance with the biostatistics. We would like to thank Rheinwald for
the kind gift of the N/TERT-1 cells. This work was funded by a United
Kingdom Research and Innovation Higher Education Innovation Fund award
with sponsorship from Rohto Pharmaceutical Company Limited (Kyoto,
Japan) as the industrial partner.
CONFLICT OF INTEREST
MZH, HN, and TF are employees of Rohto Pharmaceutical Company Limited,
the industrial partner for the project. The remaining authors state no conflict
of interest.
REFERENCES
Alépée N, Piroird C, Aujoulat M, Dreyfuss S, Hoffmann S, Hohenstein A,
et al. Prospective multicentre study of the U-SENS test method for skin
sensitization testing. Toxicol In Vitro 2015;30:373e82.
Andreas N, Caroline B, Leslie F, Frank G, Kimberly N, Allison H, et al. The
intra- and inter-laboratory reproducibility and predictivity of the
AL Harding et al.
Skin Irritation Gene Signature by Skin Equivalents
JID Innovations (2021), Volume 112
KeratinoSens assay to predict skin sensitizers in vitro: results of a ring-study
in five laboratories. Toxicol In Vitro 2011;25:733e44.
Arthur JS, Ley SC. Mitogen-activated protein kinases in innate immunity. Nat
Rev Immunol 2013;13:679e92.
Ashikaga T, Yoshida Y, Hirota M, Yoneyama K, Itagaki H, Sakaguchi H, et al.
Development of an in vitro skin sensitization test using human cell lines:
the human Cell Line Activation Test (h-CLAT). I. optimization of the h-CLAT
protocol. Toxicol In Vitro 2006;20:767e73.
Augustin C, Damour O. Pharmacotoxicological applications of an equivalent
dermis: three measurements of cytotoxicity. Cell Biol Toxicol 1995;11:
167e71.
Black AT, Hayden PJ, Casillas RP, Heck DE, Gerecke DR, Sinko PJ, et al.
Expression of proliferative and inflammatory markers in a full-thickness
human skin equivalent following exposure to the model sulfur mustard
vesicant, 2-chloroethyl ethyl sulfide. Toxicol Appl Pharmacol 2010a;249:
178e87.
Black AT, Joseph LB, Casillas RP, Heck DE, Gerecke DR, Sinko PJ, et al. Role
of MAP kinases in regulating expression of antioxidants and inflammatory
mediators in mouse keratinocytes following exposure to the half mustard,
2-chloroethyl ethyl sulfide. Toxicol Appl Pharmacol 2010b;245:352e60.
Blais M, Mottier L, Germain MA, Bellenfant S, Cadau S, Berthod F. Sensory
neurons accelerate skin reepithelialization via substance P in an innervated
tissue-engineered wound healing model. Tissue Eng Part A 2014;20:
2180e8.
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